Provided by Tiger Fintech (Singapore) Pte. Ltd.

MAIA Biotechnology Inc.

1.85
-0.0500-2.63%
Post-market: 1.850.00000.00%16:51 EDT
Volume:229.77K
Turnover:427.75K
Market Cap:56.07M
PE:-2.32
High:1.93
Open:1.93
Low:1.80
Close:1.90
Loading ...
Mar 24, 2023

Major Issues Report

8-K - Current report
Mar 24, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 17, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 13, 2023

Major Issues Report

8-K/A [Amend] - Current report
Feb 13, 2023

Major Issues Report

8-K - Current report
Feb 13, 2023

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Feb 06, 2023

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Feb 06, 2023

Major Issues Report

8-K - Current report
Feb 06, 2023

[Rev.]Quaterly Report

10-Q/A [Amend] - Quarterly report [Sections 13 or 15(d)]
Nov 22, 2022

Major Issues Report

8-K - Current report
Nov 09, 2022

Major Issues Report

8-K - Current report
Nov 09, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 21, 2022

Major Issues Report

8-K - Current report
Sep 07, 2022

Major Issues Report

8-K - Current report
Aug 22, 2022

Major Issues Report

8-K - Current report
Aug 22, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 10, 2022

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership